About Us
Vector Laboratories, part of Maravai LifeSciences, pioneered and is a market leader in labeling and detection reagents for immunohistochemistry, immunofluorescence, glycobiology and bioconjugation. As the first company to commercialize avidin-biotin enzyme complex kits for immunohistochemistry and antifade mounting media for immunofluorescence, Vector has since introduced over 600 reliable reagents and kits. Its product catalog includes VECTASTAIN® ABC kits, VECTASHIELD® Mounting Media, ImmPRESS® Polymer Detection Kits, TrueVIEW® Autofluorescence Quenching Kit, ImmPACT® Substrates and SoluLINK® bioconjugation technology, which allows rapid, reproducible and quantifiable conjugation of all classes of biomolecules.
These time-tested tools and methods are used by disease and therapeutics researchers around the world--from academia to industrial and clinical settings--to accelerate their lab processes and improve productivity. In fact, Vector’s labeling and detection reagents and processes are included in Standard Operating Procedures in labs around the world.
Vector’s facilities are ISO 9001:2015 certified and its research contributions have been cited in more than 350,000 scientific publications. Located in the San Francisco Bay Area, Vector was founded in 1976 by Dr. Jim Whitehead, who dedicated the company to creating the highest performing products for researchers around the world. That same commitment is present today with the high level of both product and service that Vector Laboratories is known for.
40-Year History of Quality and Innovation
1976
Vector Laboratories is founded
1980
Vector Labs first to commercialize avidin-biotin enzyme complex (VECTASTAIN® ABC kits)
1981
S.M. Hsu published that the high affinity of avidin for biotin could be used to increase the stability of the enzyme antibody complex
1986
Vector Labs launches PHOTOPROBE® Biotin
1993
Vector Labs introduced first antifade mounting media for fluorescence (VECTASHIELD® Mounting Media)
1999
Vector Labs introduced a next-generation PAP pen conforming with environmental regulations (ImmEdge™ Pen)
2000
Vector Labs introduces M.O.M.® detection kits expanding the use of unconjugated mouse primary antibodies on mouse tissue sections.
2004
Vector Labs expanded antifade mounting media with hardening formulation (VECTASHIELD® HardSet™ Mounting Media)
2005
Vector Labs developed detection reagents enabling greater access to antigens within tissues and improving multiple antigen labeling (ImmPRESS® enzyme polymer)
2007
Vector Labs introduced proprietary substrates enabling multiplexing IHC (ImmPACT® HRP substrates)
2011
Vector Labs introduced BLOXALL® Endogenous HRP and AP Blocking Solution
2014
Vector Labs introduced additional proprietary AP substrate (ImmPACT® Vector® Red substrate)
2016
Strategic investment by Maravai LifeSciences
2017
Vector Labs introduces Vector® TrueVIEW™ Autofluorescent Quenching Kit
2018
Vector Labs achieves ISO 9001:2015 certification
Vector Labs introduces VECTASHIELD® Vibrance Antifade Mounting Media
Company Information
ImmPRESS™ Polymer Detection Reagents
Vector® M.O.M. Mouse on Mouse Immunodetection Kits
Enzyme substrates
VECTASHIELD® Antifade Mounting Media
VectaCell™ Live Cell Imaging Reagents and Stains
Secondary fluorescent antibody conjugates
Immunofluorescence
Glycobiology
Immunocytochemistry
Live Cell Imaging
Carl has more than 30 years of experience in life science research and diagnostic companies including Abbott Labs, Ventana Medical Systems, Applied Biosystems and Gen-Probe. Carl took over as CEO of Gen-Probe in 2009 and focused the strategy of the company to take full advantage of its core molecular diagnostics and automation strengths. During Carl’s tenure, the company extended its recognized leadership position in the most rapidly growing segment of diagnostics.
Eric Tardif, President
Eric is an experienced investment banker and director with a focus on medical devices, life science tools and diagnostics. Most recently, he was instrumental in the turnaround and sale of Gen-Probe.
David Weber, VP and Chief Commercial Officer
David has an extensive background in directing the commercial functions of a variety of life science tools companies. Most recently, he served as Executive Vice President and Chief Commercial Officer of Affymetrix, where he helped orchestrate that company’s turnaround and ultimate sale to Thermo Fisher Scientific.
Harjit Kullar, VP, Marketing Harjit is an expert in global product marketing, channel sales and brand development. He has more than 15 years of marketing experience with a range of leading life science tools companies.
(530) 263-6817
dahlgrenpr@comcast.net
David Weber, Chief Commercial Officer
Maravai LifeSciences
(650) 697-3600
david.weber@maravai.com